K M Zanotti

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy
    K M Zanotti
    Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, Cleveland, Ohio, 44195, USA
    Gynecol Oncol 79:211-5. 2000
  2. ncbi Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy
    K M Zanotti
    Cleveland Clinic Foundation, Cleveland, OH 44012, USA
    J Clin Oncol 19:3126-9. 2001
  3. ncbi Prevention and management of antineoplastic-induced hypersensitivity reactions
    K M Zanotti
    Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Drug Saf 24:767-79. 2001
  4. ncbi Update on the diagnosis and treatment of human papillomavirus infection
    Kristine M Zanotti
    Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 69:948, 951-5, 956 passim. 2002
  5. ncbi Screening for gynecologic cancer
    K M Zanotti
    Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Ohio, USA
    Med Clin North Am 83:1467-87. 1999
  6. ncbi Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes
    A Nickles Fader
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Minim Invasive Gynecol 16:333-9. 2009
  7. ncbi Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers
    Robert J Kim
    Department of Gynecology Obstetrics, Gynecologic Oncology Program, Taussig Cancer Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A81, Cleveland, OH 44195, USA
    Gynecol Oncol 97:374-8. 2005

Collaborators

Detail Information

Publications7

  1. ncbi Treatment of relapsed carcinoma of the ovary with single-agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy
    K M Zanotti
    Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, Cleveland, Ohio, 44195, USA
    Gynecol Oncol 79:211-5. 2000
    ....
  2. ncbi Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy
    K M Zanotti
    Cleveland Clinic Foundation, Cleveland, OH 44012, USA
    J Clin Oncol 19:3126-9. 2001
    ..Presently, there is no reliable way to predict which patients may be at risk for this potentially severe adverse reaction. We developed a skin-test protocol to identify patients at high risk for HR to carboplatin chemotherapy...
  3. ncbi Prevention and management of antineoplastic-induced hypersensitivity reactions
    K M Zanotti
    Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Drug Saf 24:767-79. 2001
    ..As re-treatment may have serious consequences, careful consideration of the risks and benefits of these strategies is imperative when deciding among these options...
  4. ncbi Update on the diagnosis and treatment of human papillomavirus infection
    Kristine M Zanotti
    Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 69:948, 951-5, 956 passim. 2002
    ..We discuss the pathogenesis, clinical manifestations, detection, and treatment of HPV infections of the anogenital tract...
  5. ncbi Screening for gynecologic cancer
    K M Zanotti
    Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Ohio, USA
    Med Clin North Am 83:1467-87. 1999
    ..For the present time, educating patients with regard to the symptoms associated with these diseases and prompt evaluation of women who present with these symptoms helps limit unnecessary diagnostic delay...
  6. ncbi Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial cancer: surgical and survival outcomes
    A Nickles Fader
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Minim Invasive Gynecol 16:333-9. 2009
    ..To compare surgical and survival outcomes of patients with early-stage endometrial cancer (EC) who underwent total laparoscopic hysterectomy (TLH) or laparoscopic-assisted vaginal hysterectomy (LAVH) +/- lymphadenectomy...
  7. ncbi Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynecologic cancers
    Robert J Kim
    Department of Gynecology Obstetrics, Gynecologic Oncology Program, Taussig Cancer Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A81, Cleveland, OH 44195, USA
    Gynecol Oncol 97:374-8. 2005
    ..To characterize the incidence of skin toxicity of pegylated liposomal doxorubicin (PLD) administered at a lower dose (40 mg/m(2)) in the treatment of advanced gynecologic malignancies...